Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 30th, there was short interest totaling 34,755 shares, a growth of 382.4% from the October 15th total of 7,205 shares. Approximately 2.0% of the shares of the company are short sold. Based on an average daily volume of 36,072 shares, the short-interest ratio is currently 1.0 days.
Innovator IBD 50 ETF Trading Down 1.4%
Shares of NYSEARCA FFTY traded down $0.40 during midday trading on Thursday, hitting $29.02. The company’s stock had a trading volume of 19,493 shares, compared to its average volume of 49,612. The firm has a market capitalization of $50.78 million, a price-to-earnings ratio of 12.03 and a beta of 1.51. The stock has a fifty day moving average price of $33.71 and a 200 day moving average price of $37.15. Innovator IBD 50 ETF has a one year low of $28.62 and a one year high of $44.08.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the business. Guardian Wealth Advisors LLC NC purchased a new stake in shares of Innovator IBD 50 ETF during the second quarter worth $507,000. Kraematon Investment Advisors Inc. purchased a new position in shares of Innovator IBD 50 ETF in the second quarter valued at $1,021,000. Concurrent Investment Advisors LLC grew its position in shares of Innovator IBD 50 ETF by 11.1% in the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after purchasing an additional 6,321 shares in the last quarter. KFG Wealth Management LLC purchased a new position in shares of Innovator IBD 50 ETF in the second quarter valued at $201,000. Finally, WorthPointe LLC raised its stake in shares of Innovator IBD 50 ETF by 18.3% during the 2nd quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock valued at $1,295,000 after purchasing an additional 3,771 shares during the period.
About Innovator IBD 50 ETF
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Stories
- Five stocks we like better than Innovator IBD 50 ETF
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
